一种腺苷参与的全酶法NMN合成方法

    公开(公告)号:WO2023273959A1

    公开(公告)日:2023-01-05

    申请号:PCT/CN2022/100139

    申请日:2022-06-21

    发明人: 金彩科 赵媛

    摘要: 提供了一种腺苷参与的NMN的全酶法合成方法,所述腺苷参与的NMN的全酶法合成方法包括同一反应体系下的步骤:(A)腺苷、磷酸盐以及可被酵母细胞代谢的糖类在酵母细胞的催化作用下反应生成ATP;(B)酶促反应生产NMN的步骤,包括在NAMPT作用下,烟酰胺、PRPP以及ATP反应生成NMN、ADP以及磷酸盐的步骤;如此以将ATP的生成(再生)、NMN的合成及ATP的利用等一系列反应统一在一个反应体系内进行,即可完成NMN的高效合成。

    一种以烟酰胺为原料制备烟酰胺单核苷酸的方法

    公开(公告)号:WO2021253362A1

    公开(公告)日:2021-12-23

    申请号:PCT/CN2020/096908

    申请日:2020-06-19

    IPC分类号: C07H19/048 C07H1/00 C12P19/30

    摘要: 一种以烟酰胺为原料制备烟酰胺单核苷酸的方法,包括:在乙腈、二氯甲烷、1,2-二氯乙烷或者液态二氧化硫溶剂中,用三氟甲磺酸三甲基硅酯或四氯化锡催化烟酰胺和四乙酰核糖进行反应,调节pH值为3~5,加入甲醇钠溶液,于-15~5℃进行反应,调节pH值为3~5,用膜浓缩设备进行微滤和纳滤处理,得烟酰胺核糖溶液;在Mg离子、ATP和缓冲液存在的环境中,用烟酰胺核糖激酶催化烟酰胺核糖溶液进行反应,即得烟酰胺单核苷酸。该方法减少了对烟酰胺核糖的精制步骤,工艺更精简、成本更低廉、耗时更短,并且相较于直接采用烟酰胺核糖精制固体的酶催化过程具有更快的反应速度、更低的酶用量等优点。

    LIPONUCLEOTIDE-BASED THERAPY FOR ASTHMA
    8.
    发明申请

    公开(公告)号:WO2019005901A1

    公开(公告)日:2019-01-03

    申请号:PCT/US2018/039658

    申请日:2018-06-27

    IPC分类号: A61K31/66 C07H19/10 C12P19/30

    摘要: Compositions and method are therefore disclosed for treating asthma. In particular, disclosed a composition that contains one, two, or more cytidine diphosphate (CDP)-conjugated phospholipid precursors selected from the group consisting of CDP-choline, CDP-ethanolamine, and CDP-diacylglycerol in a pharmaceutically acceptable carrier for use in treating asthma.

    ENZYMATIC NUCLEIC ACID SYNTHESIS
    9.
    发明申请
    ENZYMATIC NUCLEIC ACID SYNTHESIS 审中-公开
    酶促核酸合成

    公开(公告)号:WO2017176541A1

    公开(公告)日:2017-10-12

    申请号:PCT/US2017/024939

    申请日:2017-03-30

    IPC分类号: C40B50/18 C12P19/30 C12Q1/68

    摘要: The disclosure provides methods for making a polynucleotide wherein the addition of nucleotides can be physically, chemically and/or enzymatically controlled. The methods include combining a selected nucleotide, cations, an error prone or template independent DNA polymerase at a reaction site including an initiator sequence attached thereto and having a 3' terminal nucleotide, wherein the reaction reagents can be modulated and under conditions that allow covalent addition of one or more of a selected nucleotide to the 3' terminal nucleotide such that the selected nucleotide becomes a 3' terminal nucleotide, and repeating the addition step until the polynucleotide is formed.

    摘要翻译: 本公开提供了用于制造多核苷酸的方法,其中核苷酸的添加可以被物理地,化学地和/或酶学地控制。 所述方法包括在包含与其连接并具有3'末端核苷酸的引发序列的反应位点组合选定的核苷酸,阳离子,易错或模板独立的DNA聚合酶,其中反应试剂可以在允许共价加成的条件下 一个或多个选择的核苷酸与3'末端核苷酸连接,使得所选择的核苷酸变成3'末端核苷酸,并且重复该加入步骤直到形成多核苷酸。

    HYPER-THERMOSTABLE LYSINE-MUTANT ssDNA/RNA LIGASES

    公开(公告)号:WO2017160788A3

    公开(公告)日:2017-09-21

    申请号:PCT/US2017/022232

    申请日:2017-03-14

    申请人: RGENE, INC.

    IPC分类号: C12P19/30 C12P19/34 C12Q1/68

    摘要: Provided herein are compositions, systems, and methods employing hyper-thermostable lysine-mutant ssDNA/RNA ligases that possesses both ssRNA ligase and ssDNA ligase activity. In certain embodiments, such hyper-thermostable lysine-mutant ssDNA/RNA ligases are used to ligate an first single stranded nucleic acid sequence with a 5' adenylated end to a second single stranded nucleic acid sequence (e.g., at a temperature of at least 75°C) to form a ligated nucleic acid sequence. In further embodiments, the ligated nucleic acid sequence is sequenced.